Cardiology

Filter

New Research into Oral Semaglutide and Heart Failure Outcomes

February 2026

The secondary SOUL trial analysis shows oral semaglutide reduces heart failure events in patients with diabetes and pre-existing heart failure.

First COVID Vaccine Increases Cardiovascular Risks; Full Course Provides Protection

COVID-19 vaccination is associated with a transient increase in cardiovascular risks, but complete vaccination significantly reduces the risk of more severe cardiovascular events.

The Burden and Management of Systemic Hypertension from a Patient Perspective

In this exclusive podcast, experts in the field, Andrew Foy, Penn State Health Milton S. Hershey Medical Center, and Ed Filippone, Sidney…

Factor XI/XIa Inhibition: ESC Update

The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…

Adults with Epilepsy Twice as Likely to Experience Strokes and Heart Attacks

Adults with epilepsy face double the risk of cardiovascular events, with enzyme-inducing antiseizure medications contributing significantly to this increased risk.

Novel Ultrasound Score Predicts Mortality in Patients with Acute Heart Failure

The venous excess ultrasound score improves mortality prediction in acute heart failure patients, offering a better assessment of venous congestion than traditional methods.

The Fate of Coronary Artery Bypass Grafting in the Elderly

Coronary artery bypass grafting (CABG) is a treatment option offered to a growing population of octogenarians, considering the constant…

Review of the European Society of Cardiology (ESC) Congress 2024

PERSONALISING cardiovascular care was the central theme at the European Society of Cardiology (ESC) Congress 2024, which took place in…

The latest issue of EMJ Cardiology

In our latest issue of EMJ Cardiology you can explore a wide range of exclusive interviews with field experts, insightful peer-reviewed…

Loading posts...

« Previous 1 … 27 28 29 30 31 … 96 Next »